CClinicalTrials.gg
CompletedNCT03737318C-RESULTSUpdated Jan 5, 2026Results posted

Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy

An interventional study of Biofeedback-ultrasound and Biofeedback--visual-acoustic in Speech Sound Disorder, sponsored by New York University. Completed at 2 sites in United States. Open to participants aged 9 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by New York University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
9 Years to 15 Years
Sex
All
01

Study summary

Children with speech sound disorder show diminished accuracy and intelligibility in spoken communication and may thus be perceived as less capable or intelligent than peers, with negative consequences for both socioemotional and socioeconomic outcomes. While most speech errors resolve by the late school-age years, between 2-5% of speakers exhibit residual speech errors (RSE) that persist through adolescence or even adulthood, reflecting about 6 million cases in the US. Both affected children/families and speech-language pathologists (SLPs) have highlighted the critical need for research to identify more effective forms of treatment for children with RSE. In a series of single-case experimental studies, research has found that treatment incorporating technologically enhanced sensory feedback (visual-acoustic biofeedback, ultrasound biofeedback) can improve speech in individuals with RSE who have not responded to previous intervention. A randomized controlled trial (RCT) comparing traditional vs biofeedback-enhanced intervention is the essential next step to inform evidence-based decision-making for this prevalent population. Larger-scale research is also needed to understand heterogeneity across individuals in the magnitude of response to biofeedback treatment.

The overall objective of this proposal is to conduct clinical research that will guide the evidence-based management of RSE while also providing novel insights into the sensorimotor underpinnings of speech. The central hypothesis is that biofeedback will yield greater gains in speech accuracy than traditional treatment, and that individual deficit profiles will predict relative response to visual-acoustic vs ultrasound biofeedback. This study will enroll n = 118 children who misarticulate the /r/ sound, the most common type of RSE. This first component of the study will evaluate the efficacy of biofeedback relative to traditional treatment in a well-powered randomized controlled trial. Ultrasound and visual-acoustic biofeedback, which have similar evidence bases, will be represented equally.

Read the detailed description

Randomized Trial Component: Previous findings suggest that biofeedback interventions can outperform traditional speech therapy for children with RSE, but the research base to date is limited to small-scale studies that do not reach the level of evidence needed to support large-scale changes in practice. The primary objective of the C-RESULTS RCT is to test the working hypothesis that a group of individuals randomly assigned to receive biofeedback-enhanced treatment will show larger and/or faster gains in /r/ production accuracy than an equivalent group receiving the same dose of non-biofeedback treatment. To test this hypothesis, n=110 children will be randomly assigned to receive a standard course of intervention with or without biofeedback. Acoustic and perceptual measures will be used to test for differences in both short-term learning of treated targets (Acquisition) and longer-term carryover of learning to untreated contexts (Generalization). In addition, a survey assessing participants' socio-emotional well-being will be collected from caregivers both pre and post treatment.

02

Conditions studied

  • Speech Sound Disorder

Keywords

  • speech, articulation, motor development
03

In context

Speech Sound Disorder

42 studies on the registry are indexed under Speech Sound Disorder; 16 are open to participants now.

This study's enrollment of 108 is above the median of 35 across 37 interventional studies indexed under Speech Sound Disorder.

Browse Speech Sound Disorder studies →

Lead sponsor

New York University is the lead sponsor of 120 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Must be between 9;0 and 15;11 years of age at the time of enrollment.
  • Must speak English as the dominant language (i.e., must have begun learning English by age 2, per parent report).
  • Must speak a rhotic dialect of English.
  • Must pass a pure-tone hearing screening at 20 decibels Hearing Level (HL).
  • Must pass a brief examination of oral structure and function.
  • Must exhibit less than thirty percent accuracy, based on trained listener ratings, on a probe list eliciting /r/ in various phonetic contexts at the word level.

Exclusion criteria

Exclusion Criteria:

  • Must not receive a T score more than 1.3 standard deviations (SD) below the mean on the Wechsler Abbreviated Scale of Intelligence-2 (WASI-2) Matrix Reasoning.
  • Must not receive a standard score below 80 on the Core Language Index of the Clinical Evaluation of Language Fundamentals-5 (CELF-5).
  • Must not exhibit voice or fluency disorder of a severity judged likely to interfere with the ability to participate in study activities.
  • Must not have an existing diagnosis of developmental disability or major neurobehavioral syndrome such as cerebral palsy, Down Syndrome, or Autism Spectrum Disorder, or major neural disorder (e.g., epilepsy, agenesis of the corpus callosum) or insult (e.g., traumatic brain injury, stroke, or tumor resection).
  • Must not show clinically significant signs of apraxia of speech or dysarthria.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Group 1

    Traditional articulation treatment

    Behavioral: Traditional articulation treatment

  • Experimental
    Group 2

    Biofeedback--visual-acoustic

    Behavioral: Biofeedback--visual-acoustic · Behavioral: Traditional articulation treatment

  • Experimental
    Group 3

    Biofeedback-ultrasound

    Behavioral: Biofeedback-ultrasound · Behavioral: Traditional articulation treatment

Interventions

  • BehavioralBiofeedback-ultrasound

    In ultrasound biofeedback, the elements of traditional treatment (auditory models and verbal descriptions of articulator placement) are enhanced with a real-time ultrasound display of the shape and movements of the tongue. One or two target tongue shapes will be selected for each participant, and a trace of the selected target will be superimposed over the ultrasound screen. Participants will be cued to reshape the tongue to match this target during /r/ production.

  • BehavioralBiofeedback--visual-acoustic

    In visual-acoustic biofeedback treatment, the elements of traditional treatment (auditory models and verbal descriptions of articulator placement) are enhanced with a dynamic display of the speech signal in the form of the real-time LPC (Linear Predictive Coding) spectrum. Because correct vs incorrect productions of /r/ contrast acoustically in the frequency of the third formant (F3), participants will be cued to make their real-time LPC spectrum match a visual target characterized by a low F3 frequency. They will be encouraged to attend to the visual display while adjusting the placement of their articulators and observing how those adjustments impact F3.

  • BehavioralTraditional articulation treatment

    Traditional articulation treatment involves providing auditory models and verbal descriptions of correct articulator placement, then cueing repetitive motor practice. Images and diagrams of the vocal tract will be used as visual aids; however, no real-time visual display of articulatory or acoustic information will be made available.

06

What researchers measure

Primary outcomes

  1. Change in F3-F2 Distance (Hz) Across Sessions, Measured From /r/ Sounds Produced in Syllables or Words During Practice.

    F3-F2 distance is a number (in Hz) that reflects how close a child's /r/ sound is to a typical adult-like /r/. Smaller numbers indicate more accurate /r/ production; larger numbers indicate a distorted /r/. In typical peers, accurate /r/ is roughly \~500 Hz, whereas distorted /r/ values are often \>1000 Hz. During Phase I (3 sessions over \~1 week), children produced /r/ in syllables/words. For this Outcome, we report change across sessions: a single model-based estimate of how much F3-F2 decreased from Session 1 to Session 3 (i.e., the rate of improvement). A more negative change indicates greater improvement.

    Time frame: Phase I: three 90-min treatment sessions delivered over ~1 week; reported value is the change from Session 1 to Session 3 (slope across sessions)

Secondary outcomes

  1. Change From Pre to Post in Percent "Correct" Ratings by Untrained Listeners, for /r/ Sounds Produced in Word Probes.

    The outcome is the percentage of untrained listeners, blinded to time point and treatment condition, who judged each /r/ production as "correct" from word-probe recordings (0-100%; higher = better). Children completed word probes at Pre and Post. Results in the table summarize change from Pre to Post using a mixed-effects model: specifically, the treatment × time interaction, which estimates the between-group difference in improvement from Pre to Post. A positive change indicates improvement.

    Time frame: Pre (before initiation of treatment) and Post (after the end of all treatment; ~10 weeks later).

  2. Impact of Speech Disorder on Social, Emotional, and Academic Well-being (Parent Survey)

    Parents completed a questionnaire assessing the impact of their child's speech disorder on social, emotional, and academic well-being. Each item was rated on a 5-point scale (1 = strongly disagree, 3 = neutral, 5 = strongly agree). Scores were averaged across items to yield an overall impact score ranging from 1 to 5, with higher values indicating a greater negative impact. A decrease from Pre to Post indicates improvement.

    Time frame: Pre (before initiation of treatment) and Post (after completion of all treatment; ~10 weeks later)

07

Results

Posted Jan 5, 2026

Participant flow

Phase 1 (Acquisition)
Participant flow — Phase 1 (Acquisition)
MilestoneGroup 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-Ultrasound
Started453231
Primary outcome assessment453231
Completed453231
Not completed000
Phase 2 (Generalization)
Participant flow — Phase 2 (Generalization)
MilestoneGroup 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-Ultrasound
Started453231
Secondary outcome assessment453231
Completed413130
Not completed411
Withdrew: Withdrawal by subject411

Outcome measures

PrimaryChange in F3-F2 Distance (Hz) Across Sessions, Measured From /r/ Sounds Produced in Syllables or Words During Practice.

F3-F2 distance is a number (in Hz) that reflects how close a child's /r/ sound is to a typical adult-like /r/. Smaller numbers indicate more accurate /r/ production; larger numbers indicate a distorted /r/. In typical peers, accurate /r/ is roughly \~500 Hz, whereas distorted /r/ values are often \>1000 Hz. During Phase I (3 sessions over \~1 week), children produced /r/ in syllables/words. For this Outcome, we report change across sessions: a single model-based estimate of how much F3-F2 decreased from Session 1 to Session 3 (i.e., the rate of improvement). A more negative change indicates greater improvement.

Time frame:
Phase I: three 90-min treatment sessions delivered over ~1 week; reported value is the change from Session 1 to Session 3 (slope across sessions)
Reported as:
Mean · Hertz / session
Change in F3-F2 Distance (Hz) Across Sessions, Measured From /r/ Sounds Produced in Syllables or Words During Practice.
Hertz / sessionGroup 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-Ultrasound
Change in F3-F2 Distance (Hz) Across Sessions, Measured From /r/ Sounds Produced in Syllables or Words During Practice.38.2 ± 66.066.7 ± 103.085.2 ± 152.0
Statistical analysis
  • Group 1: Traditional Articulation Treatment vs Group 2: Biofeedback--visual-acoustic vs Group 3: Biofeedback-Ultrasound · Regression, Linear · p = < .0001 (Two-sided test of the treatment × time interaction. Alpha = 0.05.) · Treatment × time interaction (β): 106.41 · 95% CI 63.06 to 149.76Sign convention: A more positive β indicates a more positive Session 1→3 slope in the traditional treatment group relative to the biofeedback group (reference level).
SecondaryChange From Pre to Post in Percent "Correct" Ratings by Untrained Listeners, for /r/ Sounds Produced in Word Probes.

The outcome is the percentage of untrained listeners, blinded to time point and treatment condition, who judged each /r/ production as "correct" from word-probe recordings (0-100%; higher = better). Children completed word probes at Pre and Post. Results in the table summarize change from Pre to Post using a mixed-effects model: specifically, the treatment × time interaction, which estimates the between-group difference in improvement from Pre to Post. A positive change indicates improvement.

Time frame:
Pre (before initiation of treatment) and Post (after the end of all treatment; ~10 weeks later).
Reported as:
Mean · Percent words rated correct
Change From Pre to Post in Percent "Correct" Ratings by Untrained Listeners, for /r/ Sounds Produced in Word Probes.
Percent words rated correctGroup 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-Ultrasound
Change From Pre to Post in Percent "Correct" Ratings by Untrained Listeners, for /r/ Sounds Produced in Word Probes.44.5 ± 3443.2 ± 3349.6 ± 34
Statistical analysis
  • Group 1: Traditional Articulation Treatment vs Group 2: Biofeedback--visual-acoustic vs Group 3: Biofeedback-Ultrasound · Regression, Linear · p = < .001 (Two-sided test of the treatment × time interaction. Alpha = 0.05.) · Treatment × time (linear) interaction (β: -3.12 · 95% CI -4.85 to -1.40Sign convention: Negative β indicates a smaller linear time slope in the traditional treatment group relative to the biofeedback group (reference level)
SecondaryImpact of Speech Disorder on Social, Emotional, and Academic Well-being (Parent Survey)

Parents completed a questionnaire assessing the impact of their child's speech disorder on social, emotional, and academic well-being. Each item was rated on a 5-point scale (1 = strongly disagree, 3 = neutral, 5 = strongly agree). Scores were averaged across items to yield an overall impact score ranging from 1 to 5, with higher values indicating a greater negative impact. A decrease from Pre to Post indicates improvement.

Time frame:
Pre (before initiation of treatment) and Post (after completion of all treatment; ~10 weeks later)
Reported as:
Mean · Impact score
Impact of Speech Disorder on Social, Emotional, and Academic Well-being (Parent Survey)
Impact scoreGroup 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-Ultrasound
Impact of Speech Disorder on Social, Emotional, and Academic Well-being (Parent Survey)1.9 ± 1.11.9 ± 1.12.1 ± 1.2
Statistical analysis
  • Group 1: Traditional Articulation Treatment vs Group 2: Biofeedback--visual-acoustic vs Group 3: Biofeedback-Ultrasound · Regression, Linear · p = .80 (Two-sided test of the treatment × time interaction. Alpha = 0.05.) · Treatment × time linear interaction (β): 0.0147 · 95% CI -0.10 to 0.13Sign convention: positive β indicates a larger linear time slope in the traditional group relative to the biofeedback group (reference level)

Adverse events

Collected over From enrollment until end of follow-up, roughly 13 weeks". Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Group 1: Traditional Articulation Treatment0/45 (0%)0/45 (0%)0/45 (0%)
Group 2: Biofeedback--visual-acoustic0/32 (0%)0/32 (0%)0/32 (0%)
Group 3: Biofeedback-Ultrasound0/31 (0%)0/31 (0%)0/31 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Group 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-UltrasoundTotal
Mean10.72 ± 1.5410.86 ± 1.8710.71 ± 1.310.8 ± 1.57
Sex: Female, Male
Sex: Female, Male(Participants)Group 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-UltrasoundTotal
Female1516940
Male30162268
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Group 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-UltrasoundTotal
American Indian or Alaska Native0000
Asian1012
Native Hawaiian or Other Pacific Islander0000
Black or African American0011
White36312794
More than one race5016
Unknown or Not Reported3115
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Group 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-UltrasoundTotal
Hispanic or Latino4138
Not Hispanic or Latino40292594
Unknown or Not Reported1236
Response to dynamic assessment session
Response to dynamic assessment session(Participants)Group 1: Traditional Articulation TreatmentGroup 2: Biofeedback--visual-acousticGroup 3: Biofeedback-UltrasoundTotal
High initial responders21141550
Low initial responders24181658
08

Study locations

2 sites
  • Montclair State University
    Bloomfield, New Jersey 07003, United States
  • Syracuse University
    Syracuse, New York 13244, United States
09

References and documents

Publications

  • Preston JL, McCabe P, Tiede M, Whalen DH. Tongue shapes for rhotics in school-age children with and without residual speech errors. Clin Linguist Phon. 2019;33(4):334-348. doi: 10.1080/02699206.2018.1517190. Epub 2018 Sep 10. PubMed 30199271 ↗
  • Preston JL, McAllister T, Phillips E, Boyce S, Tiede M, Kim JS, Whalen DH. Treatment for Residual Rhotic Errors With High- and Low-Frequency Ultrasound Visual Feedback: A Single-Case Experimental Design. J Speech Lang Hear Res. 2018 Aug 8;61(8):1875-1892. doi: 10.1044/2018_JSLHR-S-17-0441. PubMed 30073249 ↗
  • Dugan SH, Silbert N, McAllister T, Preston JL, Sotto C, Boyce SE. Modelling category goodness judgments in children with residual sound errors. Clin Linguist Phon. 2019;33(4):295-315. doi: 10.1080/02699206.2018.1477834. Epub 2018 May 24. PubMed 29792525 ↗
  • Preston JL, Holliman-Lopez G, Leece MC. Do Participants Report Any Undesired Effects in Ultrasound Speech Therapy? Am J Speech Lang Pathol. 2018 May 3;27(2):813-818. doi: 10.1044/2017_AJSLP-17-0121. PubMed 29546269 ↗
  • Preston JL, McAllister Byun T, Boyce SE, Hamilton S, Tiede M, Phillips E, Rivera-Campos A, Whalen DH. Ultrasound Images of the Tongue: A Tutorial for Assessment and Remediation of Speech Sound Errors. J Vis Exp. 2017 Jan 3;(119):55123. doi: 10.3791/55123. PubMed 28117824 ↗
  • Preston JL, Leece MC, Maas E. Motor-based treatment with and without ultrasound feedback for residual speech-sound errors. Int J Lang Commun Disord. 2017 Jan;52(1):80-94. doi: 10.1111/1460-6984.12259. Epub 2016 Jun 14. PubMed 27296780 ↗
  • Campbell H, Harel D, Hitchcock E, McAllister Byun T. Selecting an acoustic correlate for automated measurement of American English rhotic production in children. Int J Speech Lang Pathol. 2018 Nov;20(6):635-643. doi: 10.1080/17549507.2017.1359334. Epub 2017 Aug 10. PubMed 28795872 ↗
  • Campbell H, McAllister Byun T. Deriving individualised /r/ targets from the acoustics of children's non-rhotic vowels. Clin Linguist Phon. 2018;32(1):70-87. doi: 10.1080/02699206.2017.1330898. Epub 2017 Jul 13. PubMed 28703653 ↗
  • McAllister Byun T. Efficacy of Visual-Acoustic Biofeedback Intervention for Residual Rhotic Errors: A Single-Subject Randomization Study. J Speech Lang Hear Res. 2017 May 24;60(5):1175-1193. doi: 10.1044/2016_JSLHR-S-16-0038. PubMed 28389677 ↗
  • McAllister Byun T, Tiede M. Perception-production relations in later development of American English rhotics. PLoS One. 2017 Feb 16;12(2):e0172022. doi: 10.1371/journal.pone.0172022. eCollection 2017. PubMed 28207800 ↗
  • McAllister Byun T, Campbell H. Differential Effects of Visual-Acoustic Biofeedback Intervention for Residual Speech Errors. Front Hum Neurosci. 2016 Nov 11;10:567. doi: 10.3389/fnhum.2016.00567. eCollection 2016. PubMed 27891084 ↗
  • McAllister Byun T, Halpin PF, Szeredi D. Online crowdsourcing for efficient rating of speech: a validation study. J Commun Disord. 2015 Jan-Feb;53:70-83. doi: 10.1016/j.jcomdis.2014.11.003. Epub 2014 Dec 15. PubMed 25578293 ↗
  • Hitchcock ER, Byun TM, Swartz M, Lazarus R. Efficacy of Electropalatography for Treating Misarticulation of /r/. Am J Speech Lang Pathol. 2017 Nov 8;26(4):1141-1158. doi: 10.1044/2017_AJSLP-16-0122. PubMed 28834534 ↗
  • Harel D, Hitchcock ER, Szeredi D, Ortiz J, McAllister Byun T. Finding the experts in the crowd: Validity and reliability of crowdsourced measures of children's gradient speech contrasts. Clin Linguist Phon. 2017;31(1):104-117. doi: 10.3109/02699206.2016.1174306. Epub 2016 Jun 7. PubMed 27267258 ↗
  • Hitchcock ER, Harel D, Byun TM. Social, Emotional, and Academic Impact of Residual Speech Errors in School-Aged Children: A Survey Study. Semin Speech Lang. 2015 Nov;36(4):283-94. doi: 10.1055/s-0035-1562911. Epub 2015 Oct 12. PubMed 26458203 ↗
  • Hitchcock ER, Byun TM. Enhancing generalisation in biofeedback intervention using the challenge point framework: a case study. Clin Linguist Phon. 2015 Jan;29(1):59-75. doi: 10.3109/02699206.2014.956232. Epub 2014 Sep 12. PubMed 25216375 ↗
  • Byun TM, Hitchcock ER, Swartz MT. Retroflex versus bunched in treatment for rhotic misarticulation: evidence from ultrasound biofeedback intervention. J Speech Lang Hear Res. 2014 Dec;57(6):2116-30. doi: 10.1044/2014_JSLHR-S-14-0034. PubMed 25088034 ↗
  • Byun TM, Hitchcock ER. Investigating the use of traditional and spectral biofeedback approaches to intervention for /r/ misarticulation. Am J Speech Lang Pathol. 2012 Aug;21(3):207-21. doi: 10.1044/1058-0360(2012/11-0083). Epub 2012 Mar 21. PubMed 22442281 ↗
  • McAllister T, Preston JL, Hitchcock ER, Hill J. Protocol for Correcting Residual Errors with Spectral, ULtrasound, Traditional Speech therapy Randomized Controlled Trial (C-RESULTS RCT). BMC Pediatr. 2020 Feb 11;20(1):66. doi: 10.1186/s12887-020-1941-5. PubMed 32046671 ↗

Study documents

  • Protocol and statistical analysis plan · Dec 8, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03737318
Lead sponsor
New York University
Collaborators
Syracuse University, Montclair State University, National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
Sponsor
First posted
Nov 9, 2018
Start date
Mar 1, 2019
Primary completion
Aug 31, 2024
Completion
Aug 31, 2024
Results posted
Jan 5, 2026
Last update
Jan 5, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion